Utilisation des génériques de la buprénorphine haut dosage (BHD) : évaluation qualitative
Therapie, 69 3 (2014) 239-241
Published online: 2014-06-16
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
A mixed-methods study investigating the potential and challenges of generic substitution of controlled substances in community pharmacies
I.M. Keller, J.M. Alexa, M.W. Meier and S.S. AllemannExploratory Research in Clinical and Social Pharmacy 19 100622 (2025)
https://doi.org/10.1016/j.rcsop.2025.100622
Novel forms of injectable buprenorphine and French model of opioid use disorder treatment
Maryse Lapeyre-MestreTherapies 75 (5) 393 (2020)
https://doi.org/10.1016/j.therap.2020.09.007
Are patients’ pejorative representations of buprenorphine associated with their level of addiction and of misuse?
Paul Vanderkam, Stéphanie Gagey, Pierre Ingrand, et al.Drug and Alcohol Dependence 188 10 (2018)
https://doi.org/10.1016/j.drugalcdep.2018.03.033
Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment
Philippe Binder, Nassir Messaadi, Marie-Christine Perault-Pochat, et al.Journal of Addictive Diseases 35 (2) 101 (2016)
https://doi.org/10.1080/10550887.2015.1136494
Caractéristiques des sujets sous traitement de substitution vus en médecine générale d’après l’enquête nationale OPEMA 2013
Gaëtan Gentile, Elisabeth Frauger, Adeline Giocanti, et al.Therapies 71 (3) 307 (2016)
https://doi.org/10.1016/j.therap.2016.02.001